Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016). [electronic resource]
Producer: 20190621Description: 151-159 p. digitalISSN:- 1573-7217
- Adult
- Aged
- Antineoplastic Agents, Immunological -- administration & dosage
- Australia -- epidemiology
- Breast Neoplasms -- drug therapy
- Cohort Studies
- Female
- Humans
- Middle Aged
- Molecular Targeted Therapy
- Public Health Surveillance
- Receptor, ErbB-2 -- metabolism
- Retreatment
- Retrospective Studies
- Survival Analysis
- Trastuzumab -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.